Alerts will be sent to your verified email
Verify EmailORCHPHARMA
|
Orchid Pharma
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.86 % | 16.89 % | 34.65 % |
|
5yr average Equity Multiplier
|
1.61 | 2.16 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
0.5 | 0.75 | 0.74 |
|
5yr Avg Net Profit Margin
|
0.56 % | 10.24 % | 35.51 % |
|
Price to Book
|
2.9 | 5.08 | 16.03 |
|
P/E
|
70.81 | 56.36 | 87.77 |
|
5yr Avg Cash Conversion Cycle
|
52.03 Days | -15.25 Days | -112.39 Days |
|
Inventory Days
|
112.47 Days | 71.73 Days | 22.82 Days |
|
Days Receivable
|
86.58 Days | 106.89 Days | 70.51 Days |
|
Days Payable
|
159.29 Days | 179.29 Days | 130.88 Days |
|
5yr Average Interest Coverage Ratio
|
3.01 | 8.9 | 216.76 |
|
5yr Avg ROCE
|
3.08 % | 17.89 % | 45.66 % |
|
5yr Avg Operating Profit Margin
|
11.84 % | 18.12 % | 47.34 % |
|
5 yr average Debt to Equity
|
0.37 | 0.67 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | -2.66 % | 10.07 % |
|
5yr Average Return on Assets
|
1.2 % | 7.7 % | 26.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.84 % | 72.5 % | 70.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.3 % |
|
Change in Promoter Holding (3 Yrs)
|
-20.12 % | -2.5 % | -4.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
15.59 % | 2.45 % | 1.14 % |
|
Orchid Pharma
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|